Less than 24hrs before #WorldAspergillosisDay2022
We have a wide range of multi-disciplinary staff involved in every step of diagnosis and treatment, giving talks on all aspects of aspergillosis - and it is free to attend.
#IDtwitter#MedEd
https://t.co/IvZl2mWVhv
Each additional day of antibiotic therapy is associated with measurable antibiotic harm, particularly adverse events
🆕💥💥 @CMIJournal@BRxAD et Al
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis #IDTwitter
https://t.co/ERlUZ1ict6
📢Are you enthusiastic with broad General Medicine experience and an interest in Infectious Diseases?
We are recruiting for 3 junior clinical fellows in infectious diseases.
To find out more and apply visit 👇
Closing date is 7 June.
#IDTwitter
https://t.co/n4dy7IsrBV
📢We are recruiting!
The post-holder will facilitate Infectious Diseases undergraduate teaching and take a coordinating role for the medical students who are attached to the Infectious Diseases team.
To find out more 👇
https://t.co/jBn7df2BIG
This @NYTmag piece from @DrHelenOuyang is important journalism at its best, & also most heart-rending. COVID19 is doing incredible damage - worse still when badly funded health systems are already fragile & failing poorly served communities https://t.co/97pIqRUcrk
1/
Why is tricuspid valve (TV) endocarditis more common in those who use intravenous drugs?
The portal of entry for most bacteria is the venous system. If quick access to the right-heart were enough, TV endocarditis would be more common in everyone.
There must be more to it...
📢Are you an enthusiastic and enquiring clinician?
We are looking for a full-time Clinical Fellow to join the Infectious Diseases Service and the National Aspergillosis Centre.
#nhs#healthcare#mycology#infectiousdiseases
https://t.co/GSD1rvF5ZM
@DrPJLillie Type 1 MIs typically occur due to rupture of already established atherosclerotic plaques, different mechanism for venous thrombosis. Could be that inflammatory response to flu more likely to destabilise plaques than response to COVID.